1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Exosome Diagnostics and Therapeutics: Global Markets

Exosome Diagnostics and Therapeutics: Global Markets

  • March 2016
  • -
  • BCC Research
  • -
  • 159 pages

This BCC Research report provides an overview of the current state of the exosome industry, existing products on the market and detailed analysis of the competitive environments, including new potential markets for novel products, diagnostics and therapeutics development. Forecast provided for the period 2016-2021.

Use this report to:

Gain insight into the current state of the exosome industry and existing products on the market.
Analyze competitive environments, including new potential markets for novel products, diagnostics and therapeutics development.
Learn about significant players in the exosome industry, trends, obstacles, and other information effecting exosome market development.
Identify the main positive and negative factors within each sector.

Highlights

The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million in 2021, a five-year compound annual growth rate (CAGR) of 47.3%.
Diagnostics is the largest sector of the market, expected to grow from $10.0 million in 2016 to $100.0 million in 2021 at a CAGR of 58.5% for the period.
Therapeutics is expected to grow from $5.0 million in 2016 to $10.0 million in 2021, a CAGR of 14.9%.

STUDY GOALS AND OBJECTIVES

This BCC Research report, Exosome Diagnostics and Therapeutics: Global Markets, provides an overview of the current state of the exosome industry, existing products on the market and detailed analysis of the competitive environments, including new potential markets for novel products, diagnostics and therapeutics development. The study includes information about significant players in this field of study, trends and obstacles and other information affecting exosome market development.

REASONS FOR DOING THIS STUDY

In the last decade, scientific research showed exponential growth in scientificpublication on exosomes, cell-derived vesicles.

By definition, exosomes are small membrane vesicles that are released by both healthy and cancerous cells. Substances from cell cytoplasm, such as genomic DNA (deoxyribonucleic acid), various RNA (ribonucleic acid) species, proteins and lipids are encapsulated into exosomes and are shed into the extracellular environment.
Importantly, research showed that all fluids in the human body contain exosomes, which can transfer cytoplasmic ingredients to other cells either locally or at distant sites. Once reaching the recipient cells, cytoplasmic ingredients can alter its biology.

Today, it is obvious that exosome research has enormous diagnostics and therapeutics potential. Since exosomes can be isolated from bodily fluids by ultracentrifugation and filtration, as well as by other approaches, they offer a very attractive alternative to invasive biopsy for the diagnosis and monitoring of cancer. The exosomes approach represents the opportunity to expand and develop new diagnostics tools in segments
such as liquid biopsy market, a growing sector in cancer diagnostics. Moreover, exosome research offers new alternatives for therapeutics development in general, especially in the sector of drug delivery platforms.

This report will highlight the main segments of the exosome industry and its major market participants, including current and future market trends. Drivers and challenges in each segment of this industry will be discussed in detail, including forecast for the next five years.



Table Of Contents

Exosome Diagnostics and Therapeutics: Global Markets
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
SCOPE AND FORMAT 2
METHODOLOGY AND INFORMATION SOURCES 3
INTENDED AUDIENCE 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 3
BCC RESEARCH WEBSITE 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
SUMMARY TABLE GLOBAL MARKET FOR EXOSOME INDUSTRY BY SECTOR,
THROUGH 2021 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR EXOSOME INDUSTRY BY SECTOR,
2014-2021 ($ MILLIONS) 7
CHAPTER 3 INTRODUCTION TO EXOSOME MARKET 9
OVERVIEW 9
EXOSOME DEFINITION AND NOMENCLATURE 9
TABLE 1 NOMENCLATURE OF EXOSOME PARTICLES 9
DISCOVERY OF EXOSOMES 9
TABLE 2 PUBLICATION TREND ON EXOSOME SUBJECT, 2003-2015 (NO. OF
PUBLICATIONS) 10
FIGURE 1 PUBLICATION TREND ON EXOSOME SUBJECT, 2003-2015 (NO. OF
PUBLICATIONS) 10
EXOSOME BIOGENENSIS AND PROCESSING 11
TABLE 3 STEPS IN EXOSOME BIOGENESIS AND PROCESSING 11
TABLE 4 PROTEINS ESSENTIAL IN EXOSOME BIOGENESIS AND PROCESSING 12
EXOSOME COMPONENTS 13
DNA in Exosomes 13
Proteins in Exosome 13
TABLE 5 PROTEINS FOUND IN EXOSOMES 13
RNA in Exosomes 14
TABLE 6 MICRORNA IN DIFFERENT BODILY FLUIDS 14
ISOLATION AND DETECTION OF EXOSOMES 15
Isolation Techniques 15
TABLE 7 METHODS FOR EXOSOME ISOLATION 15
Differential Centrifugation 17
FIGURE 2 DIFFERENTIAL CENTRIFUGATION PROCESS 17
Density Gradient Centrifugation 17
Size-Exclusion Chromatography 18
Filtration 18
FIGURE 3 CILIATED POROUS DEVICE DESIGNED TO ISOLATE EXOSOMES BY
FILTRATION 18
Polymer-Based Precipitation 19
Immunological Separation 19
Isolation by Sieving 19
FIGURE 4 SIEVING MODELS FOR EXOSOME FILTRATION 19
TABLE 8 DISTRIBUTION OF EXOSOMES ISOLATION PROCEDURES IN THE STUDIES
CATALOGED IN EXOCARTA (%) 20
Exosome Detection 20
BIOINFORMATICS DATABASES FOR EXOSOME RESEARCH AND PRODUCT
DEVELOPMENT 23
ExoCarta 23
TABLE 9 STATISTICS OF DATA CATALOGED IN EXOCARTA, 2012 24
Vesiclepedia 24
TABLE 10 STATISTICS OF DATA CATALOGED IN VESICLEPEDIA, 2012 24
EVpedia 25
TABLE 11 STATISTICS OF DATA CATALOGED IN EVPEDIA, 2014 25
TABLE 12 COMPARISON OF DATABASES FOR EXOSOME STUDIES 26
EXOSOME FUNCTION AND PHYSIOLOGY 27
CHAPTER 4 EXOSOME DIAGNOSTICS MARKET 30
OVERVIEW 30
EXOSOMAL PROTEINS AS DIAGNOSTIC BIOMARKERS 30
TABLE 13 EXOSOMAL PROTEINS FOR CLINICAL DIAGNOSTIC APPLICATIONS 30
EXOSOMAL NUCLEIC ACIDS AS DIAGNOSTIC BIOMARKERS 32
TABLE 14 EXOSOMAL MICRORNA FOR CLINICAL DIAGNOSTIC APPLICATIONS 32
CANCER DIAGNOSTICS AS MARKET POTENTIAL FOR EXOSOME
DIAGNOSTICS PRODUCT DEVELOPMENT 35
Prostate Cancer as Potential for Diagnostics Development in
Exosome Sector 35
TABLE 15 STATISTICS FOR PROSTATE CANCER, 2015 35
TABLE 16 GLOBAL MARKET VALUE FOR PROSTATE CANCER DIAGNOSTICS AND
RELATED COST ($ BILLIONS) 36
Breast Cancer as Potential for Diagnostics Development in Exosome
Sector 37
TABLE 17 STATISTICS FOR BREAST CANCER, 2015 37
TABLE 18 GLOBAL MARKET VALUE FOR BREAST CANCER DIAGNOSTICS, THROUGH
2019 ($ BILLIONS) 39
Bladder Cancer as Potential for Diagnostics Development in Exosome
Sector 40
TABLE 19 STATISTICS FOR BLADDER CANCER, 2015 41
TABLE 20 GLOBAL MARKET VALUE FOR BLADDER CANCER DIAGNOSTICS, 2015 ($
BILLIONS) 42
Ovarian Cancer as Potential for Diagnostics Development in Exosome
Sector 43
TABLE 21 STATISTICS FOR OVARIAN CANCER, 2015 43
TABLE 22 GLOBAL MARKET VALUE FOR OVARIAN CANCER DIAGNOSTICS, 2015 ($
MILLIONS) 44
Lung Cancer as Potential for Diagnostics Development in Exosome
Sector 45
TABLE 23 STATISTICS FOR LUNG CANCER, 2015 45
TABLE 24 GLOBAL MARKET VALUE FOR LUNG CANCER DIAGNOSTICS, 2015 ($
MILLIONS) 46
Liquid Biopsy as Potential for Diagnostics Development in Exosome
Sector 46
TABLE 25 LIQUID VS. TISSUE BIOPSY 47
TABLE 26 GLOBAL MARKET VALUE FOR LIQUID BIOPSY MARKET, 2015 AND 2020 ($
BILLIONS) 48
CNS DISORDERS AND NEURODEGENRATION DISEASES AS MARKET
POTENTIAL FOR EXOSOME DIAGNOSTICS PRODUCT DEVELOPMENT 48
TABLE 27 U.S. STATISTICS DATA FOR ALZHEIMER'S, 2015 (MILLIONS/$ BILLIONS) 49
TABLE 28 GLOBAL MARKET VALUE FOR ALZHEIMER'S DIAGNOSTICS, 2009 AND
2014 ($ BILLIONS) 50
INFECTIOUS DISEASES AS MARKET POTENTIAL FOR EXOSOME
DIAGNOSTICS PRODUCT DEVELOPMENT 51
TABLE 29 GLOBAL STATISTICS DATA FOR HEPATITIS C INFECTION, 2015 (MILLIONS) 51
TABLE 30 GLOBAL MARKET VALUE FOR HEPATITIS C DIAGNOSTICS, 2015 ($
BILLIONS) 52
CARDIOVASCULAR DISEASES AS MARKET POTENTIAL FOR EXOSOME
DIAGNOSTICS PRODUCT DEVELOPMENT 53
TABLE 31 U.S. STATISTICS DATA FOR CARDIOVASCULAR DISEASES, 2011 53
TABLE 32 GLOBAL MARKET VALUE FOR CARDIOVASCULAR DIAGNOSTICS, 2015 ($
BILLIONS) 54
PRENATAL TESTING AS MARKET POTENTIAL FOR EXOSOME DIAGNOSTICS
PRODUCT DEVELOPMENT 55
TABLE 33 GLOBAL MARKET VALUE FOR PRENATAL DIAGNOSTICS, PREDICTIVE
TESTS AND NEONATAL MONITORING, THROUGH 2019 ($ BILLIONS) 55
MARKET PARTICIPANTS IN EXOSOME-BASED DIAGNOSTICS SECTOR 56
EXOSOME DIAGNOSTICS 56
Research Tools/Kits 56
Diagnostics Market/Liquid Biopsy 57
TABLE 34 COMPARISON OF EXOSOME DIAGNOSTICS APPROACH TO OTHER LIQUID
BIOPSY PLATFORMS 59
ExoDx Lung(ALK) and ExoDx Lung(EGFR T790M) for Lung Cancer
Patients 59
ExoIntelliScore Prostate 60
Solid Tumor Mutation Panel 60
Partnerships 60
EXOSOME SCIENCES/AETHLON MEDICAL 62
CARIS LIFE SCIENCES 63
NANOSOMIX 65
AMARANTUS BIOSCIENCE 66
YMIR GENOMICS 67
SISTEMIC 68
EXOSOMICS SIENA SPA 68
ORION PHARMA 69
NX PHARMAGEN 70
EVALUATION OF CURRENT DIAGNOSTICS SECTOR IN EXOSOME MARKET 71
TABLE 35 GLOBAL MARKET SIZE FOR DIAGNOSTICS EXOSOME MARKET, THROUGH
2021 ($ MILLIONS) 72
FIGURE 5 GLOBAL MARKET SIZE FOR DIAGNOSTICS EXOSOME MARKET, 2014-2021
($ MILLIONS) 72
CHAPTER 5 EXOSOME THERAPEUTICS MARKET 75
OVERVIEW 75
INTRINSIC THERAPEUTIC ACTIVITY 75
IMMUNOLOGICAL COMPATIBILITY 76
CARGO CAPABILITIES 76
GENERATION OF EXOSOME-MEDIATED THERAPEUTICS 77
Exosome Isolation and Purification from Biofluids or Cell Culture 77
Exosome-Producing Cells as a Source for Exosome Production 77
Engineering Exosomes as Therapeutic Delivery Vehicles 78
Protein Cargo 78
RNA Cargo 78
Targeting Exosomes to Specific Recipient Cells 79
Designing Exosome as Synthetic Vector 79
TABLE 36 EXAMPLES OF PHYSIOLOGICAL EFFECT OF EXOSOME DELIVERY 80
MARKET POTENTIAL FOR EXOSOME THERAPEUTICS 81
TABLE 37 TOP FIVE VACCINE PROVIDERS, 2014 ($ BILLIONS) 81
MARKET PARTICIPANTS IN EXOSOME-BASED THERAPEUTICS SECTOR 83
ATHELON MEDICAL 83
TABLE 38 MARKET FOR AETHLON MEDICAL, 2012-2015 ($ MILLIONS) 85
PANACEA PHARMACEUTICAL 85
REDERMIS 86
CODIAK BIOSCIENCES 86
EXOVITA BIOSCIENCES 87
BIOREGENERATIVE SCIENCES 88
AEGLE THERAPEUTICS 90
TABLE 39 U.S. STATISTICS FOR BURN INJURIES, 2015 91
TABLE 40 U.S. STATISTICS FOR PRESSURE ULCER 91
CAPRICOR 92
TABLE 41 REVENUE, COST AND PROFITS FOR CAPRICOR THERAPEUTICS,
2011-2014 ($ MILLIONS) 92
EXOCYTE THERAPEUTICS 93
RENEURON 93
MEDISTEM/INTREXON CORP 95
THERAPEUTICS SOLUTIONS INTERNATIONAL 95
DREIROSEN PHARMA 96
PARADIGM BIOPHARMACEUTICALS 97
ADDITIONAL PHARMA AND BIOTECH COMPANIES WITH POTENTIAL
EXOSOME RESEARCH PROJECTS 97
CLINICAL TRIALS AS INDICATOR FOR EXOSOME MARKET DEVELOPMENT 98
TABLE 42 EXAMPLES OF CLINICAL TRIALS IN U.S. USING EXOSOME APPROACH 98
EVALUATION OF CURRENT THERAPEUTICS SECTOR IN EXOSOME MARKET 99
TABLE 43 GLOBAL MARKET SIZE OF THERAPEUTICS EXOSOME MARKET, THROUGH
2021 ($ MILLIONS) 100
FIGURE 6 GLOBAL MARKET SIZE OF THERAPEUTICS EXOSOME MARKET, 2014-2021
($ MILLIONS) 101
CHAPTER 6 EXOSOME REAGENTS AND RESEARCH TOOLS MARKET 103
OVERVIEW 103
TABLE 44 MAIN STEPS IN EXOSOME RESEARCH APPROACH 103
ISOLATION METHODOLOGIES AND REAGENTS FOR EXOSOME RESEARCH 103
TABLE 45 EXAMPLES OF COMMERCIAL KITS AND REAGENTS FOR EXOSOME
ISOLATION 104
TABLE 46 PERCENTAGE OF USE OF EACH ISOLATION TECHNIQUE FOR EXOSOME
BY PURIFICATION 106
Detection Methodologies and Reagents for Exosome Research 106
Instruments for Exosome Detection 107
Nanosight NTA from Nanosight 107
qNano from Izon Science 108
ZetaView from Particle Metrix 109
Detection of Exosomes by Enzymatic Assay or ELISA Approach 109
TABLE 47 EXAMPLES OF DETECTION ASSAY 110
TABLE 48 EXAMPLES OF ANTIBODY PROVIDERS FOR EXOSOME RESEARCH 112
Characterization Methods and Reagents for Exosome Research 114
Protein Content Characterization 114
Nucleic Acid Content Characterization 115
TABLE 49 EXAMPLES OF RNA EXTRACTION COMMERCIAL KITS 115
TABLE 50 USAGE PERCENTAGE OF CHARACTERIZATION TECHNIQUES FOR
EXOSOME SAMPLE 117
Engineering Methods and Reagents for Exosome Research 117
SBI Engineering Tools 117
Evomic Science Engineering Approach 118
Ciloa's Exosome Engineering Platform 119
Excytex and Its Synthetic Liposome/Exosome 120
Additional Products and Reagents for Exosome Research 121
TABLE 51 EXAMPLES OF PURIFIED EXOSOMES COMMERCIAL PRODUCTS 121
MARKET PARTICIPANTS FOR REAGENTS AND TOOLS FOR EXOSOME RESEARCH 123
SYSTEM BIOSCIENCES (SBI) 123
HANSABIOMED 123
101BIO 124
EVOMIC SCIENCE 124
AMSBIO 124
CELL GUIDANCE SYSTEMS 125
CILOA 125
EXCYTEX 126
NANOSIGHT 127
IZON SCIENCE 127
EVALUATION OF CURRENT TOOLS AND REAGENTS SECTOR IN EXOSOME
MARKET 127
TABLE 52 GLOBAL MARKET SIZE OF EXOSOME RESEARCH TOOLS AND REAGENTS
MARKET, THROUGH 2021 ($ MILLIONS) 128
FIGURE 7 GLOBAL MARKET SIZE OF EXOSOME RESEARCH TOOLS AND REAGENTS
MARKET, 2013-2021 ($ MILLIONS) 128
CHAPTER 7 PATENT ANALYSIS OF EXOSOME MARKET 131
OVERVIEW 131
TABLE 53 NUMBER OF PATENTS FILED IN SPECIFIC YEARS ON EXOSOME RESEARCH,
2000-2015 131
FIGURE 8 NUMBER OF PATENTS FILED IN SPECIFIC YEARS ON EXOSOME RESEARCH,
2000-2015 131
TABLE 54 EXAMPLES OF PATENTS FILED ON EXOSOME RESEARCH 132
TABLE 55 SEARCH ANALYSIS FOR PATENTS USING SPECIFIC KEYWORDS (NO. OF
PATENTS) 134
FIGURE 9 SEARCH ANALYSIS FOR PATENTS USING SPECIFIC KEYWORDS (NO. OF
PATENTS) 134
CHAPTER 8 IMPACT OF EXOSOME RESEARCH ON SPECIFIC BIOPHARMACEUTICALS
MARKETS 138
OVERVIEW 138
EXOSOME RESEARCH IMPACT ON BIOMARKER AND DIAGNOSTICS
INDUSTRY 138
TABLE 56 EXAMPLES OF PROTEIN MARKERS IN EXOSOMES AND THEIR RELATED
PATHOLOGY 138
EXOSOME RESEARCH IMPACT ON MICRORNA MARKET 139
TABLE 57 EXAMPLES OF MICRORNA MARKERS IN EXOSOMES AND THEIR RELATED
PATHOLOGY 139
EXOSOME RESEARCH IMPACT ON LIQUID BIOPSY MARKET 140
TABLE 58 LIQUID VS. TISSUE BIOPSY 140
EXOSOME RESEARCH IMPACT ON STEM CELL TECHNOLOGIES MARKET 141
EXOSOME RESEARCH IMPACT ON PRENATAL DIAGNOSTICS MARKET 143
TABLE 59 GLOBAL MARKET VALUE FOR PRENATAL DIAGNOSTICS, PREDICTIVE
TESTS AND NEONATAL MONITORING, THROUGH 2019 ($ BILLIONS) 144
CHAPTER 9 MARKET SUMMARY 147
TABLE 60 GLOBAL MARKET FOR EXOSOME INDUSTRY BY SECTOR, THROUGH 2021
($ MILLIONS) 149
FIGURE 10 GLOBAL MARKET FOR EXOSOME INDUSTRY BY SECTOR, 2014-2021 ($
MILLIONS) 149
TABLE 61 EXAMPLES OF MAIN MARKET PARTICIPANTS IN EXOSOME MARKET
RESEARCH AND DEVELOPMENT 150
CHAPTER 10 SELECT COMPANIES OVERVIEW 154
AETHLON MEDICAL INC. 154
EXOSOME DIAGNOSTICS INC. 155
NANOSOMIX INC. 156
SYSTEM BIOSCIENCES (SBI) 158
THERMO FISHER SCIENTIFIC INC. 159
YMIR GENOMICS LLC 160
CHAPTER 11 LIST OF THE COMPANIES MENTIONED IN REPORT 163
101BIO 163
AEGLE THERAPEUTICS 163
AETHLON MEDICAL INC. 163
AMARANTUS BIOSCIENCE HOLDINGS INC. 163
AMSBIO LLC 163
BIOREGENERATIVE SCIENCES INC. 163
CAPRICOR THERAPEUTICS 164
CARIS LIFE SCIENCES 164
CELL GUIDANCE SYSTEMS LLC 164
CILOA 164
CODIAK BIOSCIENCES 164
DREIROSEN PHARMA 164
EVOMIC SCIENCE LLC 165
EXCYTEX 165
EXIQON, INC 165
EXOCYTE THERAPEUTICS PTE LTD. 165
EXOSOME DIAGNOSTICS INC. 165
EXOSOME SCIENCE 165
EXOSOMICS SIENA SPA 166
EXOVITA BIOSCIENCES 166
HANSABIOMED 166
ITH, IMMUNE THERAPY HOLDINGS AB 166
IZON SCIENCE 166
JSR MICRO INC. 166
MEDISTEM/INTREXON CORP. 167
MILTENYI BIOTEC GMBH 167
NANOSIGHT/MALVERN INSTRUMENTS LTD. 167
NANOSOMIX INC. 167
NEW ENGLAND PEPTIDE INC. 167
NORGEN BIOTEK CORP 167
NX PHARMAGEN 168
ORION PHARMA LTD. 168
PANACEA PHARMACEUTICALS 168
PARADIGM BIOPHARMACEUTICALS 168
PARTICLE METRIX INC. 168
PFIZER 168
PROMEGA CORP. 169
QIAGEN 169
REDERMIS 169
RENEURON GROUP PLC 169
SISTEMIC 169
SYSTEM BIOSCIENCES (SBI) 170
THERAPEUTICS SOLUTIONS INTERNATIONAL 170
THERMOFISHER SCIENTIFIC 170
YMIR GENOMICS LLC 170

LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR EXOSOME INDUSTRY BY SECTOR, THROUGH
2021 ($ MILLIONS) 7
TABLE 1 NOMENCLATURE OF EXOSOME PARTICLES 9
TABLE 2 PUBLICATION TREND ON EXOSOME SUBJECT, 2003-2015 (NO. OF
PUBLICATIONS) 10
TABLE 3 STEPS IN EXOSOME BIOGENESIS AND PROCESSING 11
TABLE 4 PROTEINS ESSENTIAL IN EXOSOME BIOGENESIS AND PROCESSING 12
TABLE 5 PROTEINS FOUND IN EXOSOMES 13
TABLE 6 MICRORNA IN DIFFERENT BODILY FLUIDS 14
TABLE 7 METHODS FOR EXOSOME ISOLATION 15
TABLE 8 DISTRIBUTION OF EXOSOMES ISOLATION PROCEDURES IN THE STUDIES
CATALOGED IN EXOCARTA (%) 20
TABLE 9 STATISTICS OF DATA CATALOGED IN EXOCARTA, 2012 24
TABLE 10 STATISTICS OF DATA CATALOGED IN VESICLEPEDIA, 2012 24
TABLE 11 STATISTICS OF DATA CATALOGED IN EVPEDIA, 2014 25
TABLE 12 COMPARISON OF DATABASES FOR EXOSOME STUDIES 26
TABLE 13 EXOSOMAL PROTEINS FOR CLINICAL DIAGNOSTIC APPLICATIONS 30
TABLE 14 EXOSOMAL MICRORNA FOR CLINICAL DIAGNOSTIC APPLICATIONS 32
TABLE 15 STATISTICS FOR PROSTATE CANCER, 2015 35
TABLE 16 GLOBAL MARKET VALUE FOR PROSTATE CANCER DIAGNOSTICS AND
RELATED COST ($ BILLIONS) 36
TABLE 17 STATISTICS FOR BREAST CANCER, 2015 37
TABLE 18 GLOBAL MARKET VALUE FOR BREAST CANCER DIAGNOSTICS, THROUGH
2019 ($ BILLIONS) 39
TABLE 19 STATISTICS FOR BLADDER CANCER, 2015 41
TABLE 20 GLOBAL MARKET VALUE FOR BLADDER CANCER DIAGNOSTICS, 2015 ($
BILLIONS) 42
TABLE 21 STATISTICS FOR OVARIAN CANCER, 2015 43
TABLE 22 GLOBAL MARKET VALUE FOR OVARIAN CANCER DIAGNOSTICS, 2015 ($
MILLIONS) 44
TABLE 23 STATISTICS FOR LUNG CANCER, 2015 45
TABLE 24 GLOBAL MARKET VALUE FOR LUNG CANCER DIAGNOSTICS, 2015 ($
MILLIONS) 46
TABLE 25 LIQUID VS. TISSUE BIOPSY 47
TABLE 26 GLOBAL MARKET VALUE FOR LIQUID BIOPSY MARKET, 2015 AND 2020 ($
BILLIONS) 48
TABLE 27 U.S. STATISTICS DATA FOR ALZHEIMER'S, 2015 (MILLIONS/$ BILLIONS) 49
TABLE 28 GLOBAL MARKET VALUE FOR ALZHEIMER'S DIAGNOSTICS, 2009 AND 2014
($ BILLIONS) 50
TABLE 29 GLOBAL STATISTICS DATA FOR HEPATITIS C INFECTION, 2015 (MILLIONS) 51
TABLE 30 GLOBAL MARKET VALUE FOR HEPATITIS C DIAGNOSTICS, 2015 ($
BILLIONS) 52
TABLE 31 U.S. STATISTICS DATA FOR CARDIOVASCULAR DISEASES, 2011 53
TABLE 32 GLOBAL MARKET VALUE FOR CARDIOVASCULAR DIAGNOSTICS, 2015 ($
BILLIONS) 54
TABLE 33 GLOBAL MARKET VALUE FOR PRENATAL DIAGNOSTICS, PREDICTIVE TESTS
AND NEONATAL MONITORING, THROUGH 2019 ($ BILLIONS) 55
TABLE 34 COMPARISON OF EXOSOME DIAGNOSTICS APPROACH TO OTHER LIQUID
BIOPSY PLATFORMS 59
TABLE 35 GLOBAL MARKET SIZE FOR DIAGNOSTICS EXOSOME MARKET, THROUGH
2021 ($ MILLIONS) 72
TABLE 36 EXAMPLES OF PHYSIOLOGICAL EFFECT OF EXOSOME DELIVERY 80
TABLE 37 TOP FIVE VACCINE PROVIDERS, 2014 ($ BILLIONS) 81
TABLE 38 MARKET FOR AETHLON MEDICAL, 2012-2015 ($ MILLIONS) 85
TABLE 39 U.S. STATISTICS FOR BURN INJURIES, 2015 91
TABLE 40 U.S. STATISTICS FOR PRESSURE ULCER 91
TABLE 41 REVENUE, COST AND PROFITS FOR CAPRICOR THERAPEUTICS, 2011-2014
($ MILLIONS) 92
TABLE 42 EXAMPLES OF CLINICAL TRIALS IN U.S. USING EXOSOME APPROACH 98
TABLE 43 GLOBAL MARKET SIZE OF THERAPEUTICS EXOSOME MARKET, THROUGH
2021 ($ MILLIONS) 100
TABLE 44 MAIN STEPS IN EXOSOME RESEARCH APPROACH 103
TABLE 45 EXAMPLES OF COMMERCIAL KITS AND REAGENTS FOR EXOSOME
ISOLATION 104
TABLE 46 PERCENTAGE OF USE OF EACH ISOLATION TECHNIQUE FOR EXOSOME BY
PURIFICATION 106
TABLE 47 EXAMPLES OF DETECTION ASSAY 110
TABLE 48 EXAMPLES OF ANTIBODY PROVIDERS FOR EXOSOME RESEARCH 112
TABLE 49 EXAMPLES OF RNA EXTRACTION COMMERCIAL KITS 115
TABLE 50 USAGE PERCENTAGE OF CHARACTERIZATION TECHNIQUES FOR EXOSOME
SAMPLE 117
TABLE 51 EXAMPLES OF PURIFIED EXOSOMES COMMERCIAL PRODUCTS 121
TABLE 52 GLOBAL MARKET SIZE OF EXOSOME RESEARCH TOOLS AND REAGENTS
MARKET, THROUGH 2021 ($ MILLIONS) 128
TABLE 53 NUMBER OF PATENTS FILED IN SPECIFIC YEARS ON EXOSOME RESEARCH,
2000-2015 131
TABLE 54 EXAMPLES OF PATENTS FILED ON EXOSOME RESEARCH 132
TABLE 55 SEARCH ANALYSIS FOR PATENTS USING SPECIFIC KEYWORDS (NO. OF
PATENTS) 134
TABLE 56 EXAMPLES OF PROTEIN MARKERS IN EXOSOMES AND THEIR RELATED
PATHOLOGY 138
TABLE 57 EXAMPLES OF MICRORNA MARKERS IN EXOSOMES AND THEIR RELATED
PATHOLOGY 139
TABLE 58 LIQUID VS. TISSUE BIOPSY 140
TABLE 59 GLOBAL MARKET VALUE FOR PRENATAL DIAGNOSTICS, PREDICTIVE TESTS
AND NEONATAL MONITORING, THROUGH 2019 ($ BILLIONS) 144
TABLE 60 GLOBAL MARKET FOR EXOSOME INDUSTRY BY SECTOR, THROUGH 2021
($ MILLIONS) 149
TABLE 61 EXAMPLES OF MAIN MARKET PARTICIPANTS IN EXOSOME MARKET
RESEARCH AND DEVELOPMENT 150

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

  • $ 9600
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are ...

2017-2021 Enteric Diseases Diagnostic Testing Market

2017-2021 Enteric Diseases Diagnostic Testing Market

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.